The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
CHOLINESTERASES, A TARGET OF PHARMACOLOGY AND TOXICOLOGY
Open accessAbstract
BACKGROUND: Cholinesterases are a group of serine hydrolases that split the neurotransmitter acetylcholine (ACh) and terminate its action. Of the two types, butyrylcholinesterase and acetylcholinesterase (AChE), AChE plays the key role in ending cholinergic neurotransmission. Cholinesterase inhibitors are substances, either natural or man-made that interfere with the break-down of ACh and prolong its action. Hence their relevance to toxicology and pharmacology. METHODS AND RESULTS: The present review summarizes current knowledge of the cholinesterases and their inhibition. Particular attention is paid to the toxicology and pharmacology of cholinesterase-related inhibitors such as nerve agents (e.g. sarin, soman, tabun, VX), pesticides (e.g. paraoxon, parathion, malathion, malaoxon, carbofuran), selected plants and fungal secondary metabolites (e.g. aflatoxins), drugs for Alzheimer's disease (e.g. huperzine, metrifonate, tacrine, donepezil) and Myasthenia gravis (e.g. pyridostigmine) treatment and other compounds (propidium, ethidium, decamethonium). CONCLUSIONS: The crucial role of the cholinesterases in neural transmission makes them a primary target of a large number of cholinesterase-inhibiting drugs and toxins. In pharmacology, this has relevance to the treatment of neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991) · Science · doi:10.1126/science.1678899 · Cited by 2,707
Ollis, D. L., Cheah, E., Cygler, M., Dijkstra, B., Frolow, F., Franken, S. M., Harel, M., Remington, S. J., Silman, I., Schrag, J., et al. (1992) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/5.3.197 · Cited by 2,120
Mechanism of action of organophosphorus and carbamate insecticides.
Fukuto, T. R. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.9087245 · Cited by 1,003
Über humorale übertragbarkeit der Herznervenwirkung: I. Mitteilung
Loewi, O. (1921) · Pflügers Archiv für die Gesamte Physiologie des Menschen und der Tiere · doi:10.1007/bf01738910 · Cited by 861
Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans
Wessler, I., & Kirkpatrick, C. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.185 · Cited by 855
Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products
Nicolet, Y., Lockridge, O., Masson, P., Fontecilla-Camps, J. C., & Nachon, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210241200 · Cited by 840
The Molecular Forms of Cholinesterase and Acetylcholinesterase in Vertebrates
Massoulie, J., & Bon, S. (1982) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.05.030182.000421 · Cited by 814
Organophosphates⧸Nerve Agent Poisoning: Mechanism of Action, Diagnosis, Prophylaxis, And Treatment
(2004) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(04)38006-6 · Cited by 701
Cygler, M., Schrag, J. D., Sussman, J. L., Harel, M., Silman, I., Gentry, M. K., & Doctor, B. P. (1993) · Protein Science · doi:10.1002/pro.5560020309 · Cited by 565
Cholinesterase inhibitors: new roles and therapeutic alternatives
GIACOBINI, E. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.11.017 · Cited by 555
Comparison of butyrylcholinesterase and acetylcholinesterase
Chatonnet, A., & Lockridge, O. (1989) · Biochemical Journal · doi:10.1042/bj2600625 · Cited by 549
The molecular evolution of genes and proteins: a tale of two serines
Brenner, S. (1988) · Nature · doi:10.1038/334528a0 · Cited by 547
Complete amino acid sequence of human serum cholinesterase.
Lockridge, O., Bartels, C. F., Vaughan, T. A., Wong, C. K., Norton, S. E., & Johnson, L. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75818-9 · Cited by 376
Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 371
Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H., & Tur-Kaspa, I. (1996) · Nature Medicine · doi:10.1038/nm1296-1382 · Cited by 360
The biological significance of substrate inhibition: A mechanism with diverse functions
Reed, M. C., Lieb, A., & Nijhout, H. F. (2010) · BioEssays · doi:10.1002/bies.200900167 · Cited by 335
Responses of Acetylcholinesterase from Torpedo marmorata to Salts and Curarizing Drugs
CHANGEUX, J.-P. (1966) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14802-5 · Cited by 325
Johnson, G., & Moore, S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206775193127 · Cited by 321
Anti-Alzheimer and Antioxidant Activities of Coptidis Rhizoma Alkaloids
Jung, H. A., Min, B.-S., Yokozawa, T., Lee, J.-H., Kim, Y. S., & Choi, J. S. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1433 · Cited by 307
Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.
Harel, M., Sussman, J. L., Krejci, E., Bon, S., Chanal, P., Massoulié, J., & Silman, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10827 · Cited by 291
Millard, C. B., Kryger, G., Ordentlich, A., Greenblatt, H. M., Harel, M., Raves, M. L., Segall, Y., Barak, D., Shafferman, A., Silman, I., et al. (1999) · Biochemistry · doi:10.1021/bi982678l · Cited by 273
Acetylcholinesterase: How is structure related to function?
Silman, I., & Sussman, J. L. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.05.035 · Cited by 263
Amyloid–cholinesterase interactions: Implications for Alzheimer’s disease
Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261
An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase.
Ripoll, D. R., Faerman, C. H., Axelsen, P. H., Silman, I., & Sussman, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5128 · Cited by 261
Tacrine Derivatives and Alzheimers Disease
Tumiatti, V., Minarini, A., Bolognesi, M. L., Milelli, A., Rosini, M., & Melchiorre, C. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791111206 · Cited by 225
Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors
Castro, A., & Martinez, A. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206778792985 · Cited by 207
Inestrosa, N. C., Roberts, W. L., Marshall, T. L., & Rosenberry, T. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61212-8 · Cited by 183
Axelsen, P. H., Harel, M., Silman, I., & Sussman, J. L. (1994) · Protein Science · doi:10.1002/pro.5560030204 · Cited by 180
Feng, G., Krejci, E., Molgo, J., Cunningham, J. M., Massoulié, J., & Sanes, J. R. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1349 · Cited by 176
Kaizer, R. R., Corrêa, M. C., Spanevello, R. M., Morsch, V. M., Mazzanti, C. M., Gonçalves, J. F., & Schetinger, M. R. C. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.06.015 · Cited by 162
Hartmann, J., Kiewert, C., Duysen, E. G., Lockridge, O., Greig, N. H., & Klein, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04347.x · Cited by 161
Darvesh, S., Darvesh, K. V., McDonald, R. S., Mataija, D., Walsh, R., Mothana, S., Lockridge, O., & Martin, E. V. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002075 · Cited by 159
Giacobini, E. (2001) · Drugs & Aging · doi:10.2165/00002512-200118120-00001 · Cited by 155
Bartolucci, C., Perola, E., Pilger, C., Fels, G., & Lamba, D. (2000) · Proteins Structure Function and Bioinformatics · Cited by 152
Iwasaki, T., Yoneda, M., Nakajima, A., & Terauchi, Y. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.0049 · Cited by 145
Manoharan, I., Boopathy, R., Darvesh, S., & Lockridge, O. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.11.005 · Cited by 122
Darreh‐Shori, T., & Soininen, H. S. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274455 · Cited by 110
Arce, M. P., Rodrı́guez-Franco, M. I., González-Muñoz, G. C., Pérez, C., López, B., Villarroya, M., López, M. G., Garcı́a, A. G., & Conde, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900628z · Cited by 109
Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica
Kryger, G., Silman, I., & Sussman, J. L. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80008-9 · Cited by 108
The Butyrylcholinesterase Knockout Mouse as a Model for Human Butyrylcholinesterase Deficiency
Li, B., Duysen, E. G., Carlson, M., & Lockridge, O. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133330 · Cited by 107
Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology
Berson, A., Knobloch, M., Hanan, M., Diamant, S., Sharoni, M. A., Schuppli, D., Geyer, B. C., Ravid, R., Mor, T. S., Nitsch, R. M., et al. (2007) · Brain · doi:10.1093/brain/awm276 · Cited by 106
Huperzine A protects isolated rat brain mitochondria against β-amyloid peptide
Gao, X., Zheng, C. Y., Yang, L., Tang, X. C., & Zhang, H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.028 · Cited by 105
Drago, D., Bolognin, S., & Zatta, P. F. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898479 · Cited by 103
Holmes, C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.039321 · Cited by 97
Acetylcholinesterase in cell adhesion, neurite growth and network formation
Sperling, L. E., & Layer, P. G. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06237.x · Cited by 94
Kaizer, R. R., Correa, M. C. J. M., Gris, L. R. S., da Rosa, C. S., Bohrer, D., Morsch, V. M., & Schetinger, M. R. C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9725-6 · Cited by 91
Rosenberry, T. L. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.10.3834 · Cited by 87
Myasthenia gravis requiring pyridostigmine treatment in a national population cohort
Andersen, J. B., Engeland, A., Owe, J. F., & Gilhus, N. E. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03089.x · Cited by 84
Bioscavenger for Protection From Toxicity of Organophosphorus Compounds
Saxena, A., Sun, W., Luo, C., Myers, T. M., Koplovitz, I., Lenz, D. E., & Doctor, B. P. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:145 · Cited by 82
Tetramerization domain of human butyrylcholinesterase is at the C-terminus
BLONG, M. R., Bedows, E., & Lockridge, O. (1997) · Biochemical Journal · doi:10.1042/bj3270747 · Cited by 81
Glycoproteomic characterization of butyrylcholinesterase from human plasma
Kolarich, D., Weber, A., Pabst, M., Stadlmann, J., Teschner, W., Ehrlich, H. J., Schwarz, H., & Altmann, F. (2008) · PROTEOMICS · doi:10.1002/pmic.200700720 · Cited by 81
Monteiro, M. S., Quintaneiro, C., Morgado, F. M. R., Soares, A. M. V. M., & Guilhermino, L. M. (2005) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2004.12.007 · Cited by 73
Cavalli, A., Bottegoni, G., Raco, C., Vivo, M. D., & Recanatini, M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040787u · Cited by 72
Kamal, M. A., Klein, P., Luo, W., et al. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9490-y · Cited by 69
Tetrameric (G4) Acetylcholinesterase: Structure, Localization, and Physiological Regulation
Fernández, H. L., Moreno, R. D., & Inestrosa, N. C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041335.x · Cited by 68
Inhibition of two different cholinesterases by tacrine
Ahmed, M., da Rocha, J. B. T., Corrêa, M., Mazzanti, C. M. D. A., Zanin, R. F., Morsch, A., Morsch, V. M., & Schetinger, M. R. C. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.06.002 · Cited by 64
Zhang, H., & Tang, X. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01433-6 · Cited by 62
Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase.
Eichler, J., Anselment, A., Sussman, J. L., Massoulié, J., & Silman, I. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09933-x · Cited by 62
Pilger, C., Bartolucci, C., Lamba, D., Tropsha, A., & Fels, G. (2001) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(00)00056-5 · Cited by 61
Development of huperzine A and B for treatment of Alzheimer's disease
Bai, D. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779040469 · Cited by 59
Bivalent Ligands Derived from Huperzine A as Acetylcholinesterase Inhibitors
Haviv, H., Wong, D. M., Silman, I., & Sussman, J. L. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779941215 · Cited by 56
Activated transformations of organophosphorus insecticides in the case of non‐AChE inhibitory oxons
Kasagami, T., Miyamoto, T., & YAMAMOTO, I. (2002) · Pest Management Science · doi:10.1002/ps.546 · Cited by 56
Cummings, J. L., Nadel, A., Masterman, D. L., & Cyrus, P. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400211 · Cited by 54
Hemmert, A., Otto, T. C., Wierdl, M., Edwards, C. C., Fleming, C. D., MacDonald, M., Cashman, J. R., Potter, P. M., Cerasoli, D. M., & Redinbo, M. R. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.062356 · Cited by 54
Chilcott, R. P., Dalton, C. H., Hill, I. D., Davison, C. M., Blohm, K. L., Clarkson, E. D., & Hamilton, M. G. (2005) · Human & Experimental Toxicology · doi:10.1191/0960327105ht537oa · Cited by 53
Aluminum exposure and Alzheimer's disease
Jansson, E. T. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3604 · Cited by 49
Hashim, Y., Shepherd, D., Wiltshire, S., Holman, R. R., Lévy, J., Clark, A., & Cull, C. A. (2001) · Diabetologia · doi:10.1007/s001250100033 · Cited by 48
Anionic subsites of the catalytic center of acetylcholinesterase from Torpedo and from cobra venom.
Kreienkamp, H., Weise, C., Raivo, R. A. B. A., Aaviksaar, A., & Hucho, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6117 · Cited by 44
Bartolucci, C., Haller, L. A., Jordis, U., Fels, G., & Lamba, D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901296p · Cited by 43
Tacrine-induced liver damage: an analysis of 19 candidate genes
Alfirevic, A., Mills, T., Carr, D. F., Barratt, B. J., Jawaid, A., Sherwood, J. L., Smith, J. C., Tugwood, J. D., Hartkoorn, R. C., Owen, A., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f1f12b · Cited by 43
Gao, J.-R., & Zhu, K. Y. (2001) · Insect Biochemistry and Molecular Biology · doi:10.1016/s0965-1748(01)00057-1 · Cited by 39
Villarroya, M., Garcı́a, A. G., & Marco, J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383368 · Cited by 39
Role of butyrylcholinesterase in canine tracheal smooth muscle function
Adler, M., & Filbert, M. G. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80300-8 · Cited by 36
Yuan, J., Yin, J., & Wang, E. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.02.024 · Cited by 35
Mehlert, A., Varon, L. E., Silman, I., Homans, S. W., & Ferguson, M. A. J. (1993) · Biochemical Journal · doi:10.1042/bj2960473 · Cited by 31
Rivastigmine in Parkinson's disease dementia
Chitnis, S., & Rao, J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903105420 · Cited by 29
Kanamori‐Kataoka, M., & Seto, Y. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.09.044 · Cited by 28
High activity of human butyrylcholinesterase at low pH in the presence of excess butyrylthiocholine
Masson, P., Nachon, F., Bartels, C. F., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03388.x · Cited by 28
Haigh, J. R., Adler, M., Apland, J. P., Deshpande, S. S., Barham, C. B., Desmond, P. F., Koplovitz, I., Lenz, D. E., & Gordon, R. K. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.02.003 · Cited by 22
Subunit Association and Glycosylation of Acetylcholinesterase from Monkey Brain
Liao, J., Nørgaard‐Pedersen, B., & Brodbeck, U. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03629.x · Cited by 21
Stabilization ofTorpedo californicaAcetylcholinesterase by Reversible Inhibitors
Weiner, L. M., Shnyrov, V. L., Konstantinovskii, L. E., Roth, E., Ashani, Y., & Silman, I. (2008) · Biochemistry · doi:10.1021/bi801196y · Cited by 19
Ethidium bromide inhibits rat brain acetylcholinesterase activity in vitro
Mazzanti, C. M. D. A., Spanevello, R. M., Obregon, A., Pereira, L. B., Streher, C. A., Ahmed, M., Mazzantí, A., Graça, D. L., Morsch, V. M., & Schetinger, M. R. C. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.05.013 · Cited by 19
Pohanka, M., Kuča, K., & Kassa, J. (2008) · PubMed · Cited by 15
Self-citationMicrocalorimetric study of the inhibition of butyrylcholinesterase by carbamates
Debord, J., Laubarie-Mouret, C., & DANTOINE, T. F. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.023 · Cited by 14
Microcalorimetric study of the inhibition of butyrylcholinesterase by paraoxon
Debord, J., Harel, M., Verneuil, B., Bollinger, J., & DANTOINE, T. F. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.03.041 · Cited by 13
Zelinski, T. A., Coghlan, G., Mauthe, J., & Triggs‐Raine, B. L. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.10.009 · Cited by 12
Characterization of Acetylcholinesterase in Caco-2 Cells
Plageman, L. R., Pauletti, G. M., & Skau, K. A. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700712 · Cited by 11
Non‐enzymatic developmental functions of acetylcholinesterase – the question of redundancy
Johnson, G., Swart, C., & Moore, S. W. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06644.x · Cited by 9
Bajgar, J. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03341-h · Cited by 9
Sensitivity of acetylcholinesterase molecular forms to inhibition by high MgCl2 concentration
Inestrosa, N. C., Pérez, C. A., & Simpfendörfer, R. (1994) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)90115-5 · Cited by 8
Cited by
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Colovic, M. B., Krstic, D. Z., Lazarevic-Pasti, T. D., Bondzic, A. M., & Vasic, V. M. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030006 · Cited by 2,611
Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection
Singh, M., Kaur, M., Kukreja, H., Chugh, R., Silakari, O., & Singh, D. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.09.050 · Cited by 364
Sakamuru, S., Huang, R., & Xia, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935399 · Cited by 11
Metadata
- Authors
- Pohanka, M.
- Venue
- Biomedical Papers
- Publisher
- Palacky University Olomouc
- Published
- 2011-09-01
- Volume
- 155
- Issue
- 3
- Pages
- 219-223
- ISSN
- 1213-8118 (ISSN-L)
- 1804-7521
- OpenAlex
- W2114682709
- Cited by
- 376
- References
- 90
- FWCI
- 16.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.